Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Scandinavian Journal of Urology|March 18, 2026
Introduction of a modified surgical approach for ProACT balloon placement: a retrospective cohort studyJakob Klint Axelsen, Lars Boesen, Rasmus Bisbjerg, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2014
Antibiotic prophylaxis for transrectal prostate biopsy-a new strategyValeria Antsupova, Nis Nørgaard, Rasmus Bisbjerg, et al.
European Urology Open Science|February 1, 2024
Office-based Magnetic Resonance Imaging-guided Transperineal Prostate Biopsy Without Antibiotic Prophylaxis: A Real-world Clinical Utility StudyLars Boesen, Nis Nørgaard, Rasmus Bisbjerg, et al.
Prostate Cancer and Prostatic Diseases|April 17, 2019
A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsiesLars Boesen, Frederik B Thomsen, Nis Nørgaard, et al.
European Urology Oncology|June 16, 2019
Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve MenLars Boesen, Nis Nørgaard, Vibeke Løgager, et al.
JAMA Network Open|January 16, 2019
Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) StudyLars Boesen, Nis Nørgaard, Vibeke Løgager, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 18, 2021
Highlights of the development in ultrasound during the last 70 years: A historical reviewMichael Bachmann Nielsen, Stinne Byrholdt Søgaard, Sofie Bech Andersen, et al.
Oncoimmunology|January 17, 2022
Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanomaSofie Kirial Mørk, Mohammad Kadivar, Kalijn Fredrike Bol, et al.
Frontiers in Immunology|March 31, 2023
First in man study: Bcl-Xl_42-CAF<sup>®</sup>09b vaccines in patients with locally advanced prostate cancerSofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, et al.
Pageof 2